Approval · Notice of Compliance 11607 · 2010
ZEMURON: Notice of Compliance 11607
Issued July 15, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11607
- Date
- July 15, 2010
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to product monograph to include use in pediatric populations (term neonates - 3 months old)
- Therapeutic class
- Non-depolarizing skeletal neuromuscular blocking agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEMURON | Not yet assigned | — |
Medicinal ingredients
- ROCURONIUM BROMIDE 10 MG per ML